Kitonail (Ciclopirox)

Ciclopirox chelates metal ions like iron and aluminum, which are essential cofactors for fungal enzymes. By binding these metals, it blocks metal‑dependent enzymatic pathways, disrupting cellular transport, energy production, and membrane integrity, ultimately inhibiting fungal growth and replication.

The dosage and frequency of Kitonail are determined by the prescribing healthcare professional based on the specific infection, its severity, and the patient’s condition. The prescriber will provide detailed instructions on how much product to apply and how often.

Safety data for ciclopirox in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using Kitonail. The prescriber can weigh benefits against any possible concerns.

To order Kitonail, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Kitonail’s active ingredient, ciclopirox, offers a broad spectrum of activity against dermatophytes, molds, and yeasts and works by metal chelation, a mechanism different from allylamine agents like terbinafine. This can be advantageous in cases where resistance to other classes is a concern, though clinical choice depends on infection type and physician judgment.

Kitonail should be stored at ambient temperature, protected from excessive heat, moisture, and direct light. Keep the product in its original container with the cap tightly closed. Do not freeze or refrigerate unless specifically instructed on the label.

Kitonail is applied topically to the affected nail or skin area. The prescriber will advise the amount to use, typically a thin layer, and the frequency (often once or twice daily). The area should be clean and dry before application, and hands should be washed after use.

While most reactions are mild, serious risks include severe contact dermatitis, extensive skin ulceration, or systemic allergic responses such as urticaria. If any intense rash, swelling, blistering, or signs of an allergic reaction develop, the product should be discontinued and medical attention sought promptly.

Kitonail should be avoided in individuals with known hypersensitivity to ciclopirox or any component of the formulation. It is also not recommended for use on severely damaged, inflamed, or broken skin without medical advice, and patients with uncontrolled systemic fungal infections should seek alternative systemic therapy.